The U.S. Court of Appeals for the Federal Circuit has decided whether tribal sovereign immunity required termination of inter partes review (IPR) proceedings before the Patent Trial and Appeal Board (PTAB). At the PTAB, Mylan...more
7/25/2018
/ Administrative Proceedings ,
Allergan Inc ,
Appeals ,
Federal Rules of Civil Procedure ,
Inter Partes Review (IPR) Proceeding ,
IP Assignment Agreements ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Patents ,
Sovereign Immunity ,
Tribal Governments